Enhances Function News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail
An experimental treatment can essentially reverse type 1 diabetes in certain types of laboratory mice, according to a series of studies led by University of Utah Health scientists. An injection of the therapeutic agent converts cells that normally control glucose production into ones that generate insulin.
The researchers say giving the animals a single dose of a human antibody that suppress the actions of glucagon, a hormone involved in glucose regulation, sparked a remarkable transformation in the pancreas, leading to a nearly 7-fold increase in insulin cell mass and the suppression of diabetic symptoms.
These animals go from requiring insulin injections to never requiring a diabetes treatment again. They maintain normal blood glucose long after we stop the treatment, says William L. Holland, Ph.D., the study s corresponding author and a U of U Health assistant professor of Nutrition and Integrative Physiology. What this implies for millions of people wh ....

Vanderbilt University , United States , University Of Texas Southwestern Medical Center , Baylor College Of Medicine , Williaml Holland , National Institute Of Diabetes , Vanderbilt University Medical Center , Nu Health , University Of Utah Health , Administration North Texas Health Care System , Diabetes Research Foundation , Lilly Research Laboratories , Children Nutrition Research Center , Proceedings Of The National Academy Sciences , Touchstone Diabetes Center , Utah Health , National Academy , Baylor College , Texas Southwestern Medical Center , Juvenile Diabetes Research Foundation , Vanderbilt University Medical , Nutrition Research Center , Blockade Restores Functional Beta Cell Mass , Enhances Function , Human Islets , National Institute ,